Sign Out
Pregnancy: There are no adequate data from use of moxonidine in pregnant woman. Studies in animals have shown embryo-toxicological effects (see Pharmacology: Toxicology: Preclinical safety data under Actions). The potential risk for humans is unknown. Moxonidine should not be used during pregnancy unless clearly necessary.
Lactation: Moxonidine is secreted in breast milk and should therefore not be used during breast feeding. If therapy with moxonidine is considered absolutely necessary, the breast feeding shall be stopped.
